The questions within this cluster relate to the use of innovative technologies for research on new drugs. One example is lab-on-a-chip: integrating different laboratory functions on a single chip. This technology can, for example, make blood, saliva or urine tests faster and cheaper. There is also a lot of interest in this technology from developing countries, as this kind of testing requires less complicated infrastructure. In particular, the cluster focuses on the possibilities that innovative technologies offer for a greater fundamental understanding of molecular and physiological processes. This understanding can lead to new directions in research into new drugs. The development of new laboratory models for research on the human body is also of great importance here.
Connecting character
This question is relevant to both the top sector Life Sciences & Health and the top sector Chemistry. In fundamental research, the focus of this question is on the opportunities offered by innovative technologies such as stem cell technology for the development of new drugs and therapies. More applied questions address increasing the efficiency and effectiveness of the development process of new drugs. Among other things, the submitted questions focus on the opportunities for sustainable production of drugs, among others. In this cluster, cooperation between the disciplines of chemistry, biology, medicine, but also ICT or fundamental physics, for example, is of great importance.
